pioglitazone has been researched along with 8-epi-prostaglandin f2alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Everett, CJ; King, DE; Player, M | 1 |
| Hou, WK; Huang, QX; Li, MZ; Lin, P; Liu, Q; Song, J; Wang, K; Wang, Q; Xu, H; Yu, S; Zhang, L; Zhang, Y | 1 |
2 trial(s) available for pioglitazone and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes.
Topics: Academic Medical Centers; Arginine; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dinoprost; F2-Isoprostanes; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Pioglitazone; Prospective Studies; South Carolina; Thiazolidinediones; Time Factors; Treatment Outcome | 2012 |
Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Topics: Apelin; Blood Glucose; Body Mass Index; Chemokines; Diabetes Mellitus, Type 2; Dinoprost; Humans; Hypoglycemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |